Immunology and Microbiology
Microflora
100%
Airway
85%
Microbiome
79%
Infectious Agent
44%
Sputum
40%
Intestine Flora
39%
Pseudomonas aeruginosa
36%
Gut Microbiome
31%
Microbiology
29%
Asthma
25%
Real-Time Polymerase Chain Reaction
24%
Taxon
21%
Feces microflora
20%
Haemophilus influenzae
20%
Antimicrobial Resistance
17%
Microorganism
17%
Prevalence
12%
Human Microbiome
11%
Bacterial Cell
11%
Bacterial Load
11%
Severe Asthma
10%
Metabolite
10%
Interleukin 8
10%
Microbial Diversity
10%
Pyrosequencing
9%
RNA Gene
9%
Amplicon Sequencing
8%
Lower Respiratory Tract
8%
Forced Expiratory Volume
7%
Middle Ear
6%
Peritonitis
6%
Oropharynx
6%
Cytokine
6%
Immunity
6%
Gene Sequence
6%
Innate Immune System
6%
Restriction Fragment Length Polymorphism
6%
Whole Genome Sequencing
5%
Normal Human
5%
Otitis Media
5%
Bronchoalveolar Lavage Fluid
5%
Freeze Thawing
5%
Nontuberculous mycobacteria
5%
Streptococcus
5%
Metagenomics
5%
Germfree Mouse
5%
Dynamics
5%
Metabolic Regulation
5%
Clinical Decision Making
5%
Horizontal Gene Transfer
5%
Medicine and Dentistry
Cystic Fibrosis
62%
Microbiome
52%
Infection
29%
Gut Microbiome
28%
Lung
28%
Bronchiectasis
24%
Pathogen
24%
Randomized Controlled Trial
24%
Gut Microbiota
21%
Sputum
19%
Respiratory Disease
17%
Gut
16%
Antibiotic Therapy
15%
Respiratory Tract Infection
15%
Macrolide
14%
Diseases
14%
Pseudomonas aeruginosa
14%
Asthma
13%
Silo-Filler's Disease
12%
Clinical Trial
10%
Placebo
10%
Azithromycin
10%
Antibiotic Resistance
10%
Erythromycin
9%
Restriction Fragment Length Polymorphism
9%
Obesity
9%
Patient with Cystic Fibrosis
8%
Supplementation
8%
Dysbiosis
7%
Glycemic Control
7%
RNA 16S
7%
Prevalence
7%
Asthma Exacerbation
7%
Real-Time Polymerase Chain Reaction
6%
Respiratory Tract Inflammation
6%
Body Mass Index
6%
Antiinfective Agent
6%
Aged Care
6%
Fecal Microbiota Transplantation
6%
Chronic Lung Disease
6%
Ascites
6%
Interleukin 1beta Converting Enzyme
6%
Inflammasome
6%
Patient Care
6%
Antimicrobial Therapy
6%
Antibiotics
6%
Haemophilus influenzae
5%
Diagnosis
5%
Lung Infection
5%
Low Drug Dose
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
47%
Microflora
28%
Pseudomonas aeruginosa
21%
Microbiome
21%
Infection
16%
Macrolide
13%
Feces microflora
13%
Bronchiectasis
10%
Almond
10%
Antibiotics
9%
Erythromycin
9%
Diseases
8%
Antibiotic Therapy
8%
Lung Infection
8%
Antimicrobial Therapy
7%
Intestine Flora
7%
Respiratory Tract Infection
6%
Randomized Controlled Trial
6%
Lung Disease
6%
Clinical Trial
6%
Azithromycin
6%
Infectious Agent
5%
Respiratory Tract Disease
5%
Placebo
5%
Microorganism
5%
